Elevated level of plasma vascular endothelial growth factor after gonadotropin-releasing hormone agonist treatment for leiomyomata

Gynecological Endocrinology

Volumn 24, Issue 12, 2008, Pages 724-726

  Takeda, Takashi ^a   Osuga, Keigo ^a   Miyake, Asako ^a   Wakabayashi, Atsuko ^a   Morishige, Ken Ichirou ^a   Kimura, Tadashi ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

gonadotropin releasing hormone agonist; uterine leiomyomata; Vascular endothelial growth factor

Indexed keywords

EDETIC ACID; GONADORELIN AGONIST; VASCULOTROPIN; GONADORELIN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TREATMENT OUTCOME; TREATMENT RESPONSE; UTERUS MYOMA; BLOOD; DRUG POTENTIATION; LEIOMYOMA; METHODOLOGY; MIDDLE AGED; PROSPECTIVE STUDY; UTERINE ARTERY EMBOLIZATION; UTERUS CANCER;

ADULT; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; LEIOMYOMA; MIDDLE AGED; PROSPECTIVE STUDIES; UTERINE ARTERY EMBOLIZATION; UTERINE NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 64349086183     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09513590802454901     Document Type: Article

References (15)

1. Cramer SF, Patel A. The frequency of uterine leiomyomas. Am J Clin Pathol 1990;94:435-438.
2. Lepine LA, Hillis SD, Marchbanks PA, Koonin LM, Morrow B, Kieke BA, Wilcox LS. Hysterectomy surveillance - United States, 1980-1993. MMWR CDC Surveill Summ 1997;46:1- 15.
3. Ravina JH, Herbreteau D, Ciraru-Vigneron N, Bouret JM, Houdart E, Aymard A, Merland JJ. Arterial embolisation to treat uterine myomata. Lancet 1995;346:671-672.
4. Walker WJ, Pelage JP. Uterine artery embolisation for symptomatic fibroids: clinical results in 400 women with imaging follow up. BJOG 2002;109:1262-1272.
5. Volkers NA, Hehenkamp WJ, Birnie E, Ankum WM, Reekers JA. Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: 2 years' outcome from the randomized EMMY trial. Am J Obstet Gynecol 2007;196:519.e1-519.e11.
6. Edwards RD, Moss JG, Lumsden MA, Wu O, Murray LS, Twaddle S, Murray GD; Committee of the Randomized Trial of Embolization versus Surgical Treatment for Fibroids. Uterine-artery embolization versus surgery for symptomatic uterine fibroids. N Engl J Med 2007;25;360-370.
7. Lethaby A, Vollenhoven B, Sowter M. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids. Cochrane Database Syst Rev 2001; 2:CD000547.
8. Phillips DR. GnRH analogs and uterine artery embolization. J Am Assoc Gynecol Laparosc 1999;6:368.
9. Burbank F, Hutchins FL, Jr. Uterine artery occlusion by embolization or surgery for the treatment of fibroids: a unifying hypothesis-transient uterine ischemia. J Am Assoc Gynecol Laparosc 2000;7 (4 Suppl):S1-S49.
10. Spies JB. Uterine artery embolization for fibroids: understanding the technical causes of failure. J Vasc Interv Radiol 2003;14:11-14.
11. Jelkmann W. Pitfalls in the measurement of circulating vascular endothelial growth factor. Clin Chem 2001;47:617-623.
12. Hague S, Zhang L, Oehler MK, Manek S, MacKenzie IZ, Bicknell R, Rees MC. Expression of the hypoxically regulated angiogenic factor adrenomedullin correlates with uterine leiomyoma vascular density. Clin Cancer Res 2000;6:2808-2814.
13. Huang R, Lin Y, Shi Q, Flowers L, Ramachandran S, Horowitz IR, Parthasarathy S, Huang RP. Enhanced protein profiling arrays with ELISA-based amplification for highthroughput molecular changes of tumor patients' plasma. Clin Cancer Res 2004;10:598-609.
14. Takeda T, Osuga K, Morishige K, Tasaka K, Nakamura H, Murata Y. Changes of plasma vascular endothelial growth factor level after uterine artery embolisation for leiomyomata. Br J Obstet Gynecol 2005;112:1437-1439.
15. Di Lieto A, De Falco M, Pollio F, Mansueto G, Salvatore G, Somma P, Ciociola F, De Rosa G, Staibano S. Clinical response, vascular change, and angiogenesis in gonadotropinreleasing hormone analogue-treated women with uterine myomas. J Soc Gynecol Investig 2005;12:123-128.